FORTRESS BIOTECHPRFA (Germany) Analysis
| CNB0 Stock | EUR 6.60 0.45 6.38% |
FORTRESS BIOTECHPRFA 25 is overvalued with Real Value of 5.57 and Hype Value of 6.6. The main objective of FORTRESS BIOTECHPRFA stock analysis is to determine its intrinsic value, which is an estimate of what FORTRESS BIOTECHPRFA 25 is worth, separate from its market price. There are two main types of FORTRESS BIOTECHPRFA's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect FORTRESS BIOTECHPRFA's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of FORTRESS BIOTECHPRFA's stock to identify patterns and trends that may indicate its future price movements.
The FORTRESS BIOTECHPRFA stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and FORTRESS BIOTECHPRFA's ongoing operational relationships across important fundamental and technical indicators.
FORTRESS |
FORTRESS Stock Analysis Notes
The company recorded a loss per share of 0.82. FORTRESS BIOTECHPRFA last dividend was issued on the 14th of February 2023. Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York. FORTRESS BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 111 people. For more info on FORTRESS BIOTECHPRFA 25 please contact the company at 781 652 4500 or go to http://www.fortressbiotech.com.FORTRESS BIOTECHPRFA Investment Alerts
| FORTRESS BIOTECHPRFA had very high historical volatility over the last 90 days | |
| FORTRESS BIOTECHPRFA has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 77.61 M. Net Loss for the year was (42.98 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| FORTRESS BIOTECHPRFA 25 has accumulated about 289.9 M in cash with (83.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98. |
FORTRESS BIOTECHPRFA Thematic Classifications
In addition to having FORTRESS BIOTECHPRFA stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
FORTRESS Profitablity
FORTRESS BIOTECHPRFA's profitability indicators refer to fundamental financial ratios that showcase FORTRESS BIOTECHPRFA's ability to generate income relative to its revenue or operating costs. If, let's say, FORTRESS BIOTECHPRFA is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, FORTRESS BIOTECHPRFA's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of FORTRESS BIOTECHPRFA's profitability requires more research than a typical breakdown of FORTRESS BIOTECHPRFA's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.63. Technical Drivers
As of the 20th of July, FORTRESS BIOTECHPRFA shows the Downside Deviation of 5.02, mean deviation of 3.53, and Market Risk Adjusted Performance of (1.18). FORTRESS BIOTECHPRFA technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm FORTRESS BIOTECHPRFA jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if FORTRESS BIOTECHPRFA is priced fairly, providing market reflects its regular price of 6.6 per share.FORTRESS BIOTECHPRFA Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of FORTRESS BIOTECHPRFA for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out FORTRESS BIOTECHPRFA short-term fluctuations and highlight longer-term trends or cycles.
FORTRESS BIOTECHPRFA Outstanding Bonds
FORTRESS BIOTECHPRFA issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. FORTRESS BIOTECHPRFA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most FORTRESS bonds can be classified according to their maturity, which is the date when FORTRESS BIOTECHPRFA 25 has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US34964CAE66 Corp BondUS34964CAE66 | View | |
| FBINUS 45 25 MAR 52 Corp BondUS34964CAG15 | View | |
| FBINUS 4 25 MAR 32 Corp BondUS34964CAF32 | View | |
| US34960PAD33 Corp BondUS34960PAD33 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
FORTRESS BIOTECHPRFA Predictive Daily Indicators
FORTRESS BIOTECHPRFA intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of FORTRESS BIOTECHPRFA stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
FORTRESS BIOTECHPRFA Forecast Models
FORTRESS BIOTECHPRFA's time-series forecasting models are one of many FORTRESS BIOTECHPRFA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary FORTRESS BIOTECHPRFA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About FORTRESS Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how FORTRESS BIOTECHPRFA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling FORTRESS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as FORTRESS BIOTECHPRFA. By using and applying FORTRESS Stock analysis, traders can create a robust methodology for identifying FORTRESS entry and exit points for their positions.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York. FORTRESS BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 111 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding FORTRESS BIOTECHPRFA to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Complementary Tools for FORTRESS Stock analysis
When running FORTRESS BIOTECHPRFA's price analysis, check to measure FORTRESS BIOTECHPRFA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FORTRESS BIOTECHPRFA is operating at the current time. Most of FORTRESS BIOTECHPRFA's value examination focuses on studying past and present price action to predict the probability of FORTRESS BIOTECHPRFA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FORTRESS BIOTECHPRFA's price. Additionally, you may evaluate how the addition of FORTRESS BIOTECHPRFA to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |